ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
안면 관절 주사 시장 규모는 향후 몇 년간 강력한 성장이 전망될 예정입니다. 예측 기간 동안의 성장 전망은 비오피오이드 진통제 옵션에 대한 수요 증가, 영상 유도 주사 기술의 채택 확대, 외래 및 주간 치료 절차에 대한 강조 증가, 재생 주사 요법의 사용 확대, 척추 질환 치료에 대한 의료 투자 증가에 의해 촉진될 것으로 보입니다. 이 기간 동안 예상되는 주요 동향으로는 초음파 및 형광 투시 유도 주사의 개선, 더 오래 지속되는 통증 완화를 위한 고급 의약품 제형 개발, 관절통을 위한 복합 요법의 개발, 혈소판이 풍부한 혈장 및 줄기 세포와 같은 재생 치료의 혁신, 주사 후 모니터링을 위한 웨어러블 기술의 발전 등이 있습니다.
척추 질환 및 만성 요통의 유병률이 증가함에 따라 앞으로 안면 관절 주사 시장의 성장이 촉진될 것으로 예상됩니다. 이러한 질환에는 디스크 퇴화, 관절염, 신경 압박 등이 포함되며, 지속적인 통증, 운동 범위 제한, 삶의 질 저하를 유발합니다. 척추 질환과 만성 요통의 증가세는 주로 앉아 있는 생활 방식과 나쁜 자세에 기인하며, 이는 지속적인 불편함을 완화하고 운동 기능을 회복하기 위해 효과적이고 최소 침습적인 치료법을 찾는 사람들이 증가하고 있습니다. 척추 관절 주사는 척추의 통증과 염증을 줄여 이러한 증가하는 척추 건강 문제로 고통받는 사람들에게 완화를 제공합니다. 예를 들어, 2023년 5월 미국 기반 비영리 자원 센터인 Spinal Cord Inc.는 미국에서 연간 약 1만 8,000건의 새로운 척추 손상 사례가 발생하며, 전국적으로 약 30만 2,000명이 척추 손상으로 고통받고 있다고 보고했습니다. 이로 인해 척추 질환과 만성 요통의 증가가 관절주사 시장 확장을 촉진하고 있습니다.
최소 침습적 시술에 대한 수요가 증가함에 따라 향후 몇 년 동안 안면 관절 주사 시장이 성장할 것으로 예상됩니다. 최소 침습적 시술은 작은 절개 또는 큰 수술 절개 없이 수행되는 의료 시술입니다. 환자들이 빠른 회복과 수술 후 통증의 감소를 선호하기 때문에 이러한 시술의 인기가 높아지고 있습니다. 안면 관절 주사는 광범위한 수술을 필요로 하지 않고 정확한 통증 완화 및 진단 명확성을 제공하여 이러한 시술을 지원합니다. 예를 들어, 2023년 미국 성형외과 의사 협회(미국 기반 전문 단체)는 2022년 2,370만 건에서 2023년 2,540만 건으로 최소 침습적 미용 시술 건수가 증가했다고 보고했습니다. 이에 따라 최소 침습적 치료에 대한 수요 증가가 관절면 주사 시장 확장을 촉진하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 19 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 안면 관절 주사 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 안면 관절 주사 시장 : 성장률 분석
세계의 안면 관절 주사 시장 실적 : 규모와 성장(2019-2024년)
세계의 안면 관절 주사 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 안면 관절 주사 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 안면 관절 주사 시장 : 제품 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
코르티코스테로이드
국소 마취제
히알루론산
기타 제품 유형
세계의 안면 관절 주사 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
경추추간관절
흉추추간관절
요추추간관절
추간 관절 주사
세계의 안면 관절 주사 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
외래수술센터(ASC)
전문 클리닉
기타 최종 사용자
세계의 안면 관절 주사 시장 : 코르티코스테로이드 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
트리암시놀론아세토니드
메틸프레드니솔론 아세트산염
덱사메타손 인산나트륨
베타메타손
기타 코르티코스테로이드
세계의 안면 관절 주사 시장 : 국소 마취제 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
리도카인
부피바카인
로피바카인
프리로카인
기타 국소 마취제
세계의 안면 관절 주사 시장 : 히알루론산유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
고분자량 히알루론산
저분자량 히알루론산
가교 히알루론산
비가교 히알루론산
세계의 안면 관절 주사 시장 : 기타 제품 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
다혈소판 혈장
생물학적 인자
복합제제
기타 주사제
제7장 지역별, 국가별 분석
세계의 안면 관절 주사 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 안면 관절 주사 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
안면 관절 주사 시장 :경쟁 구도
안면 관절 주사 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck & Co. Inc : 개요, 제품 및 서비스, 전략 및 재무 분석
AbbVie Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Sanofi SA : 개요, 제품 및 서비스, 전략 및 재무 분석
Medtronic plc : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Stryker Corporation
Teva Pharmaceutical Industries Ltd.
Boston Scientific Corporation
Henry Schein Inc.
Bausch Health Companies Inc.
Zimmer Biomet Holdings Inc.
Smith & Nephew plc
Dr. Reddy's Laboratories Ltd.
Arthrex Inc.
Aspen Pharmacare Holdings Limited
Pacira BioSciences Inc.
Bioventus Inc.
Ferring Pharmaceuticals
Anika Therapeutics Inc.
Symbiotec Pharmalab Pvt. Ltd.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
안면 관절 주사 시장(2029년) : 새로운 기회를 제공하는 국가
안면 관절 주사 시장(2029년) : 새로운 기회를 제공하는 부문
안면 관절 주사 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
HBR
영문 목차
영문목차
A facet joint injection is a minimally invasive procedure designed to diagnose or treat pain originating from the facet joints, which are small joints located between pairs of vertebrae in the spine. The injection usually contains a mix of a local anesthetic to numb the area and a corticosteroid to reduce inflammation. This procedure is often used to alleviate chronic pain in the neck, back, or thoracic region caused by arthritis or spinal degeneration.
The primary types of products used in facet joint injections include corticosteroids, local anesthetics, hyaluronic acid, and others. Corticosteroids are steroid hormones utilized medically to decrease inflammation and suppress immune responses. These injections are applied to various regions such as the cervical, thoracic, and lumbar facet joints, and are administered by a range of end-users including hospitals, ambulatory surgical centers, specialty clinics, and more.
The facet-joint injection market research report is one of a series of new reports from The Business Research Company that provides facet-joint injection market statistics, including the facet-joint injection industry global market size, regional shares, competitors with the facet-joint injection market share, detailed facet-joint injection market segments, market trends, and opportunities, and any further data you may need to thrive in the facet-joint injection industry. This facet-joint injection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The facet-joint injection market size has grown strongly in recent years. It will grow from $2.78 billion in 2024 to $2.97 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth observed during the historic period can be attributed to the increasing incidence of chronic back and neck pain, greater adoption of minimally invasive pain treatments, an aging population experiencing spinal degeneration, improved access to image-guided injection techniques, and heightened awareness of non-surgical pain relief methods.
The facet-joint injection market size is expected to see strong growth in the next few years. It will grow to $3.85 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The projected growth in the forecast period is driven by rising demand for non-opioid pain management options, greater adoption of image-guided injection technologies, increased emphasis on outpatient and day-care procedures, expanded use of regenerative injection therapies, and growing healthcare investments in treatments for spinal disorders. Key trends expected during this time include improvements in ultrasound and fluoroscopy-guided injections, development of advanced drug formulations for longer-lasting pain relief, creation of combination therapies for joint pain, innovations in regenerative treatments like platelet-rich plasma and stem cells, and progress in wearable technology for monitoring after injections.
The increasing prevalence of spinal diseases and chronic back pain is expected to drive the growth of the facet-joint injection market going forward. These conditions, which include disc degeneration, arthritis, and nerve compression, cause ongoing pain, limited mobility, and a lower quality of life. The rise in spinal diseases and chronic back pain is largely attributed to sedentary lifestyles and poor posture, prompting more individuals to seek effective, minimally disruptive treatments that alleviate persistent discomfort and restore movement. Facet-joint injections provide relief by reducing pain and inflammation in the spine, helping those affected by these growing spinal health issues. For example, in May 2023, Spinal Cord Inc., a U.S.-based non-profit resource center, reported that approximately 18,000 new spinal cord injury cases occur annually in the United States, with an estimated 302,000 people living with spinal cord injuries nationwide. As a result, the increasing prevalence of spinal diseases and chronic back pain is fueling the expansion of the facet-joint injection market.
The increasing demand for minimally invasive procedures is expected to drive the growth of the facet-joint injection market in the coming years. Minimally invasive procedures involve medical treatments performed through small incisions or without large surgical cuts. Their popularity is rising due to patients' preference for quicker recovery and less post-operative pain. Facet-joint injections support these procedures by offering precise pain relief and diagnostic clarity without requiring extensive surgery. For example, in 2023, the American Society of Plastic Surgeons, a U.S.-based specialty organization, reported that the number of minimally invasive cosmetic procedures increased from 23.7 million in 2022 to 25.4 million in 2023. Consequently, the growing demand for minimally invasive treatments is fueling the expansion of the facet-joint injection market.
Key players in the facet-joint injection market are concentrating on creating innovative solutions, such as facet fusion systems, to provide longer-lasting relief and enhance treatment effectiveness. Facet fusion systems are medical devices designed to stabilize and fuse the facet joints by encouraging bone growth between neighboring vertebrae. For example, in March 2025, Aurora Spine Corporation, a U.S.-based medical device manufacturer, announced that its latest product, the AERO(TM) Facet Fusion System, received 510(k) clearance from the U.S. Food and Drug Administration (FDA). This system features a titanium plasma spray coating to enhance osseointegration and fusion potential. It also offers multiple implant sizes to fit different patient anatomies and includes radiolucent instruments to improve visibility during surgery. Together, these features aim to increase procedural efficiency and improve long-term outcomes in the treatment of chronic back pain caused by facet joint disorders.
Major players in the facet-joint injection market are Pfizer Inc., Merck & Co. Inc, AbbVie Inc., Sanofi S.A., Medtronic plc, Stryker Corporation, Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Henry Schein Inc., Bausch Health Companies Inc., Zimmer Biomet Holdings Inc., Smith & Nephew plc, Dr. Reddy's Laboratories Ltd., Arthrex Inc., Aspen Pharmacare Holdings Limited, Pacira BioSciences Inc., Bioventus Inc., Ferring Pharmaceuticals, Anika Therapeutics Inc., Symbiotec Pharmalab Pvt. Ltd.
North America was the largest region in the facet-joint injection market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in facet-joint injection report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the facet-joint injection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The facet-joint injection market consists of revenues earned by entities through medication management, rehabilitation and psychological counseling, and interventional procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The facet-joint injection market also includes of sales of injection kits, imaging guidance systems, patient monitoring devices, and pain-relieving medications. Values in this market are 'factory gate' values, meaning the value of goods sold by the manufacturers or creators, whether to other companies (like distributors, clinics, and hospitals) or directly to end users. The value of goods in this market also includes related services provided by the creators, such as training or support for the use of injection products.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Facet-Joint Injection Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on facet-joint injection market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for facet-joint injection ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The facet-joint injection market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Corticosteroids; Local Anesthetics; Hyaluronic Acid; Other Product Types
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Facet-Joint Injection Market Characteristics
3. Facet-Joint Injection Market Trends And Strategies
4. Facet-Joint Injection Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Facet-Joint Injection Growth Analysis And Strategic Analysis Framework
5.1. Global Facet-Joint Injection PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Facet-Joint Injection Market Growth Rate Analysis
5.4. Global Facet-Joint Injection Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Facet-Joint Injection Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Facet-Joint Injection Total Addressable Market (TAM)
6. Facet-Joint Injection Market Segmentation
6.1. Global Facet-Joint Injection Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Corticosteroids
Local Anesthetics
Hyaluronic Acid
Other Product Types
6.2. Global Facet-Joint Injection Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cervical Facet Joints
Thoracic Facet Joints
Lumbar Facet Joints
Facet Joint Injections
6.3. Global Facet-Joint Injection Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Other End-Users
6.4. Global Facet-Joint Injection Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Triamcinolone Acetonide
Methylprednisolone Acetate
Dexamethasone Sodium Phosphate
Betamethasone
Other Corticosteroids
6.5. Global Facet-Joint Injection Market, Sub-Segmentation Of Local Anesthetics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lidocaine
Bupivacaine
Ropivacaine
Prilocaine
Other Local Anesthetics
6.6. Global Facet-Joint Injection Market, Sub-Segmentation Of Hyaluronic Acid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
High Molecular Weight Hyaluronic Acid
Low Molecular Weight Hyaluronic Acid
Cross-Linked Hyaluronic Acid
Non-Cross-Linked Hyaluronic Acid
6.7. Global Facet-Joint Injection Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Platelet-Rich Plasma
Biological Agents
Combination Formulations
Other Injectables
7. Facet-Joint Injection Market Regional And Country Analysis
7.1. Global Facet-Joint Injection Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Facet-Joint Injection Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
